| Literature DB >> 25479770 |
Yan A Ivanenkov1, Sergei V Vasilevski2, Elena K Beloglazkina3, Maksim E Kukushkin2, Alexey E Machulkin3, Mark S Veselov4, Nina V Chufarova5, Elizaveta S Chernyaginab6, Anton S Vanzcool7, Nikolay V Zyk2, Dmitry A Skvortsov2, Anastasia A Khutornenko8, Alexander L Rusanov9, Alexander G Tonevitsky10, Olga A Dontsova11, Alexander G Majouga12.
Abstract
Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics.Entities:
Keywords: 3D molecular docking; Cell-based assay; Dispiro-indolinones; MDM2/p53; PPI inhibitors
Mesh:
Substances:
Year: 2014 PMID: 25479770 DOI: 10.1016/j.bmcl.2014.09.070
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823